Jeddah, Saudi Arabia

Sami-ullah Rather

This inventor holds 1 USPTO granted patent. Top assignee: King Abdulaziz University. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sami-ullah Rather

Introduction

Sami-ullah Rather is a notable inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of antifungal treatments through his innovative research and development. His work focuses on enhancing the efficacy of existing antifungal drugs, particularly for immunocompromised patients.

Latest Patents

Sami-ullah Rather holds a patent for an "Antifungal ionic liquid and Amphotericin B combination." This patent describes ionic liquids that can be utilized as antifungal agents, either alone or in conjunction with Amphotericin B. The patent also outlines methods for synthesizing these ionic liquids and their application in inhibiting fungal growth. This combination aims to combat infections caused by drug-resistant fungi, providing a crucial solution for patients with weakened immune systems.

Career Highlights

Sami-ullah Rather is affiliated with King Abdulaziz University, where he conducts his research and development activities. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from fungal infections. With a focus on practical applications, his research is paving the way for advancements in antifungal therapies.

Collaborations

Sami-ullah Rather collaborates with esteemed colleagues, including Hisham S Bamufleh and Aqeel Ahmad Taimoor. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that encourages innovation.

Conclusion

Sami-ullah Rather's contributions to antifungal treatments exemplify the importance of innovation in addressing medical challenges. His patent and ongoing research hold promise for improving the lives of patients affected by fungal infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…